Peptides

Ultima-Semaglutide

Availability: In Stock
Wishlist
  • Active Substance: Glucagon-Like Peptide-1 (GLP-1)
  • Concentration: 5 mg
  • Pack Size: vial
  • Manufacturer: Ultima Pharmaceuticals
  • Brand Name: Semaglutide

SKU: P4096

$85.00
Shipping From
Quantity

Achieve Significant Weight Management with Ultima-Semaglutide 5mg

You're looking for a peptide primarily known for its potent effects on appetite regulation, blood sugar control, and potential for significant weight loss? Ultima-Semaglutide 5mg (Semaglutide), a GLP-1 receptor agonist, is engineered for exactly that. While not directly a performance-enhancing drug, its metabolic effects can indirectly support athletic goals.

Key Features:

  • GLP-1 Receptor Agonist: Mimics the action of the natural hormone glucagon-like peptide-1 (GLP-1).
  • Potent Appetite Suppressant: Effectively reduces hunger and cravings.
  • Promotes Significant Weight Loss: Clinically proven for substantial reductions in body weight.
  • Improves Blood Sugar Control: Enhances insulin secretion and reduces glucagon release.
  • May Offer Cardiovascular Benefits: Research suggests potential positive effects on heart health.
  • Subcutaneous Injection: Administered via convenient subcutaneous injection.
  • Ultima Quality: A research-grade GLP-1 receptor agonist.

Mechanism of Action:

Ultima-Semaglutide contains Semaglutide, a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. GLP-1 is a natural hormone that plays a crucial role in regulating appetite and blood sugar. Semaglutide works by:

  • Slowing Gastric Emptying: This leads to a feeling of fullness for longer, reducing food intake.
  • Suppressing Appetite: It acts on the brain to reduce hunger signals and cravings.
  • Stimulating Insulin Release: In response to high blood sugar levels, it increases insulin secretion from the pancreas.
  • Inhibiting Glucagon Release: It reduces the secretion of glucagon, a hormone that raises blood sugar levels.

Benefits (Potential Indirect Athletic Use):

  • Significant Weight Loss: Can help athletes in weight-sensitive sports or those aiming for a leaner physique.
  • Improved Body Composition: Loss of fat mass can lead to a better power-to-weight ratio.
  • Enhanced Metabolic Health: Improved blood sugar control and insulin sensitivity can benefit overall energy levels and recovery.
  • Potential for Reduced Inflammation: Some research suggests GLP-1 receptor agonists may have anti-inflammatory effects.

Use in Combination:

Ultima-Semaglutide is primarily used for weight management and metabolic health. Its combination with other substances should be approached with caution and under informed guidance:

  • Other Weight Loss Agents: Combining with other appetite suppressants or fat burners could increase the risk of side effects.
  • Anabolic Agents: While not a direct synergy for muscle growth, Semaglutide could help maintain a leaner physique during bulking phases.
  • Insulin Sensitizers: Caution is advised when combining with other drugs that affect blood sugar.

Possible Combinations in Sports:

Ultima-Semaglutide's primary role is not direct performance enhancement, but it can be relevant in sports where weight and body composition are factors:

  • Weight-Class Sports (e.g., Boxing, MMA, Wrestling): Facilitating weight management to compete in specific weight categories.
  • Endurance Sports: Achieving a leaner physique can improve efficiency.
  • Aesthetics-Focused Sports (e.g., Bodybuilding, Physique): Reducing body fat to enhance muscle definition.

Usage Guidelines:

Ultima-Semaglutide is administered via subcutaneous injection. The dosing schedule typically involves a gradual increase to minimize gastrointestinal side effects:

  • Administration: Subcutaneous injection, typically in the abdomen, thigh, or upper arm. Follow specific reconstitution and injection instructions provided with the product.
  • Dosage: Dosing regimens vary but often start with a low dose (e.g., 0.25 mg once weekly) and gradually increase every 4 weeks as tolerated to a maintenance dose (e.g., 1-2.4 mg once weekly, depending on the specific goal and individual response). The 5mg vial will contain multiple doses.
  • Timing: Typically administered once weekly, on the same day each week, at any time of day.
  • Cycle Length: Can be used for extended periods for chronic weight management. Duration should be determined based on individual goals and response.
  • Storage: Store the lyophilized powder in a cool, dry place. Once reconstituted, refrigerate and use within the recommended timeframe (typically a few weeks).

Cycles Examples (for weight management - not typical "athletic" cycles):

The following is a general example of a titration schedule for weight management. Always consult with a healthcare professional for personalized guidance:

  • Weeks 1-4: 0.25 mg once weekly.
  • Weeks 5-8: 0.5 mg once weekly.
  • Weeks 9-12: 1.0 mg once weekly.
  • Maintenance: May increase to 1.7 mg or 2.4 mg once weekly based on response and tolerance.

This 5mg vial could support several weeks of treatment depending on the dosage used.

Potential Side Effects:

The most common side effects of Semaglutide are gastrointestinal in nature, especially during the initial dose titration period:

  • Nausea.
  • Vomiting.
  • Diarrhea.
  • Constipation.
  • Abdominal pain.
  • Decreased appetite (this is also the intended therapeutic effect).
  • Rarely, more serious side effects can occur, such as pancreatitis or gallbladder issues.

Avoiding Side Effects:

To minimize potential side effects:

  • Start with a very low dose and gradually increase according to a recommended titration schedule.
  • Ensure adequate hydration.
  • Eat smaller, more frequent meals.
  • Avoid high-fat and greasy foods, especially during the initial phase.
  • Report any severe or persistent side effects to a healthcare professional.

What is Ultima-Semaglutide?

Ultima-Semaglutide contains Semaglutide, a GLP-1 receptor agonist primarily used for weight loss and blood sugar control.

How might Semaglutide indirectly benefit athletes?

Indirect benefits may include significant weight loss, improved body composition, enhanced metabolic health, and potential for reduced inflammation.

How is Semaglutide administered and what is the typical dosage?

Semaglutide is administered via subcutaneous injection once weekly. Dosing typically starts low and gradually increases to a maintenance dose.

What are the potential side effects?

The most common side effects are gastrointestinal, such as nausea, vomiting, diarrhea, and abdominal pain.